Close

Axsome Therapeutics (AXSM) received from FDA proposed labeling for AXS-05 product candidate with respect to its NDA for AXS-05 for treatment of major depressive disorder

Go back to Axsome Therapeutics (AXSM) received from FDA proposed labeling for AXS-05 product candidate with respect to its NDA for AXS-05 for treatment of major depressive disorder

Form 8-K Axsome Therapeutics, For: Jun 24

June 27, 2022 7:06 AM EDT

8-K... More